Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
EV/Core EBITDA

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 19.5611.296.365.920.11

What is the latest EV/Core EBITDA ratio of WINDLAS BIOTECH ?

The latest EV/Core EBITDA ratio of WINDLAS BIOTECH is 19.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202519.56
Mar202411.29
Mar20236.36
Mar20225.92
Mar20210.11

How is EV/Core EBITDA of WINDLAS BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 19.56
73.25
Mar2024 11.29
77.52
Mar2023 6.36
7.43
Mar2022 5.92
5,281.82
Mar2021 0.11 -

Other Financial Ratios of WINDLAS BIOTECH


Compare EV/Core EBITDA ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,689.6 Cr 3.5% 9.6% -21.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

3.5%

9.6%

-21.4%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses